Company Profile

Optimum Technologies Inc
Profile last edited on: 4/4/23      CAGE: 4Q7R7      UEI: JJV2YZ38SM17

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
1994
First Award
2001
Latest Award
2020
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

114 Pleasant Street
Southbridge, MA 01550
   (774) 200-9061
   info@optimum-tech.com
   www.optimum-tech.com
Location: Single
Congr. District: 01
County: Worcester

Public Profile

Optimum Technologies is a full-service product development and early stage manufacturing company specializing in optical technologies for the life sciences.Expertise is the design, prototyping, and production of opto-mechanical and electro-optical devices and instruments for the medical, dental, laboratory, drug discovery, and genomic/proteomic markets. Optimum Technologies, Inc. is developing proprietary technology and instruments in the area of in-vivo, real-time, optical cancer detection. This fiberoptic based technology uses elastic scattering spectroscopy (ESS) to instantly differentiate healthy from cancerous tissues in many organ systems, including GI, bladder, mouth, and skin.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2020 1 AF $49,997
Project Title: Optimum Technologies Cislunar Architecture
2010 2 NIH $315,423
Project Title: Optically-Guided Bladder Biopsy Using Polarized Elastic Scattering Spectroscopy
2009 1 NIH $370,934
Project Title: Easy-To-Use, Low-Cost, Handheld Retinal Camera For Screening For Diabetic Retinop
2007 2 NIH $1,406,463
Project Title: Polarized Probe for Fiberoptic In-vivo Spectroscopy
2001 1 NIH $99,890
Project Title: Handheld Device For Cost-Effective Retinal Screening

Key People / Management

  Randal B Chinnock -- President Founder and CEO

  Frederick George Bargoot

  Sally Chinnock

  Yasmin Colon -- QA Specialist

  Simon Dawson

  George Grubner -- Program Manager

  John Hildebrand -- COO

Company News

There are no news available.